Related references
Note: Only part of the references are listed.Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015
Dawn K. Smith et al.
ANNALS OF EPIDEMIOLOGY (2018)
Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia
David P. Serota et al.
CLINICAL INFECTIOUS DISEASES (2018)
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study
Robert M. Grant et al.
CLINICAL INFECTIOUS DISEASES (2018)
Preferences for Injectable PrEP Among Young US Cisgender Men and Transgender Women and Men Who Have Sex with Men
Katie B. Biello et al.
ARCHIVES OF SEXUAL BEHAVIOR (2018)
Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study
Elizabeth F. Closson et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2018)
Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection
Peng Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
Steven A. John et al.
AIDS AND BEHAVIOR (2018)
Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States
D. Kerrigan et al.
AIDS AND BEHAVIOR (2018)
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
Sybil G. Hosek et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Challenges in Translating PrEP Interest Into Uptake in an Observational Study of Young Black MSM
Charlotte-Paige Rolle et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
Alex Carballo-Dieguez et al.
PLOS ONE (2017)
Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence
Jessica E. Haberer et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2017)
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Jean-Michel Molina et al.
LANCET HIV (2017)
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
Martin Markowitz et al.
LANCET HIV (2017)
Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project
Stefanie J. Vaccher et al.
FRONTIERS IN PUBLIC HEALTH (2017)
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
Alex Carballo-Dieguez et al.
AIDS AND BEHAVIOR (2017)
A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men
Lisa A. Eaton et al.
PREVENTION SCIENCE (2017)
Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among US Men Who Have Sex with Men
George J. Greene et al.
AIDS AND BEHAVIOR (2017)
Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature
Florence M. Koechlin et al.
AIDS AND BEHAVIOR (2017)
Lifetime risk of a diagnosis of HIV infection in the United States
Kristen L. Hess et al.
ANNALS OF EPIDEMIOLOGY (2017)
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)
Craig W. Hendrix et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2016)
Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014
Brooke E. Hoots et al.
CLINICAL INFECTIOUS DISEASES (2016)
Enhancing PrEP Access for Black and Latino Men Who Have Sex With Men
Corina Lelutiu-Weinberger et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United States
Eric William Hall et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2016)
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Sheena McCormack et al.
LANCET (2016)
A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
Erica Schlesinger et al.
PHARMACEUTICAL RESEARCH (2016)
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
Ian McGowan et al.
LANCET HIV (2016)
Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of US Men Who have Sex with Men (MSM)
Steven A. Elsesser et al.
AIDS AND BEHAVIOR (2016)
Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the US
Jeffrey T. Parsons et al.
AIDS AND BEHAVIOR (2016)
Minimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with Men
Lisa A. Eaton et al.
AIDS PATIENT CARE AND STDS (2015)
A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02)
Hiwot Hiruy et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
J. -M. Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Attitudes and Perceptions of Biomedical HIV Prevention Methods: Voices from Young Men Who Have Sex with Men
Katrina Kubicek et al.
ARCHIVES OF SEXUAL BEHAVIOR (2015)
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Robert M. Grant et al.
LANCET INFECTIOUS DISEASES (2014)
High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort Substudy
Kathrine Meyers et al.
PLOS ONE (2014)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ATTITUDES AND PROGRAM PREFERENCES OF AFRICAN-AMERICAN URBAN YOUNG ADULTS ABOUT PRE-EXPOSURE PROPHYLAXIS (PrEP)
Dawn K. Smith et al.
AIDS EDUCATION AND PREVENTION (2012)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men - Opportunities for advancing HIV prevention in the third decade of HIV/AIDS
DA MacKellar et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Share Paper
